CO-NEWMONT-CORP
14.4.2022 17:02:12 CEST | Business Wire | Press release
Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2021 Sustainability Report as part of its suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220414005599/en/
“Newmont has a long tradition of setting and transparently reporting against public targets. With this report, we offer stakeholders a clear and comprehensive understanding of our most material sustainability topics,” said Tom Palmer, Newmont President and CEO. “As the world’s leading gold company, our ESG practices are woven into the fabric of our company as we work to deliver on our purpose: to create value and improve lives through sustainable and responsible mining.”
Highlights of Newmont’s 2021 Sustainability Report:
- Commitment to health and safety: Achieved zero work-related fatalities for the third year in a row. Further embedded our Fatality Risk Management program with a focus on verifying the critical controls that prevent fatalities and coaching frontline leaders to provide visible, felt leadership.
- Response to COVID-19: Continued to put the health, safety and wellbeing of our workforce and host communities at the heart of every decision the Company made. Newmont strongly supported COVID-19 vaccines as they became available and adopted the position of requiring all employees and third-party workers to be fully vaccinated. With contributions through Newmont’s Global Community Support Fund, the Company supported COVID-19 testing facilities, vaccine awareness campaigns and vaccine rollouts in areas near our operations.
- Sustainability-linked financial performance: Established the industry’s first sustainability-linked bond, holding Newmont to account for meeting our 2030 emissions reductions targets and to achieve gender parity in senior leadership roles by 2030. This represents the next step in aligning our business to our commitments and values by linking the interest rate payout to our performance on key ESG priorities.
- Value sharing: Newmont played an important role in creating economic value in host communities and jurisdictions, contributing $10.8 billion to its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties and taxes. This includes spending $1.4 billion with local and Indigenous suppliers, $21.9 million in community investments and providing ongoing opportunities for local and Indigenous employment, along with an additional $3.5 million from Newmont’s Global Community Support Fund.
Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:
- Recognized as a leading gold miner for the seventh consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be ranked as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
- Earned a rating of “AA” from MSCI, putting Newmont in the top quartile for precious metals and mining;
- Listed as sixth overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
- Included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace for the fourth successive year;
- Named to the JUST 100 as one of America’s most JUST companies by JUST Capital and CNBC, included in the JUST 100 and named Industry Leader for 2022; and
- One of the most transparent companies in the S&P 500, according to Bloomberg’s ESG Disclosure Score.
Newmont’s 2021 Sustainability Report is written in accordance with the GRI 2016 Universal Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining standards and is externally assured by an independent third-party. Additionally, Newmont’s sustainability report aligns with ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.
The full 2021 Sustainability Report, along with the ESG data tables and comprehensive GRI and SASB content indices, is available for download on Newmont’s website .
About Newmont
Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.
At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220414005599/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release
Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 08:03:00 CEST | Press release
Round led by SBI Group follows $51 million Series B raise in May 2026, marking ascent as one of the fastest-growing neobanking platforms. Capital will expand Own Network and deepen AI across stablecoin settlement, tokenization, and corridor banking. Fasset now processes more than $40 billion in annualized transaction volume, serving 3 million+ wallets and more than 1,000 enterprises across 125 countries. Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 07:11:00 CEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 01:01:00 CEST | Press release
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 21:11:00 CEST | Press release
Authorizations add selection of ZYN ULTRA products to PMI U.S.’s growing portfolio of better alternatives for legal-age adults who smoke or use traditional oral tobacco products Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to furth
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
